Abstract:Latin America is a geographic region that shares cultural and genetic characteristics that may influence the susceptibility of its population to various diseases, including acute lymphoblastic leukemia (ALL), the most common form of childhood cancer, and acute promyelocytic leukemia (APL), which is also frequently observed among Hispanic populations (1). Notably, childhood ALL in Latino and Hispanic populations is associated with a lower frequency of gene rearrangements linked to favorable outcomes, alongside higher frequencies of gene patterns associated with poorer prognosis. Unfortunately, this corresponds with lower survival rates. It's important to recognize that the exact causes of leukemia are not fully understood, and only a limited number of risk factors have been identified (2)(3)(4)(5)(6).This Research Topic is devoted to current and in-progress scientific knowledge on epidemiological, biological and clinical aspects of acute leukemias in children and their control in the Latin American region. "Childhood Leukemias in Latin America: Epidemiology, Causality, Novel Predictive Profiles and Therapeutic Strategies" includes 17 Original Research articles, 2 Reviews, 1 Methods and 1 Perspective article, providing a comprehensive overview of the advancements in some of the malignant diseases that have been extremely heterogeneous and a cause of long-term diseases in Latin America.In this Research Topic, expert authors explore the epidemiology, causation, prevention, pathobiology, diagnosis, novel predictive profiles, and therapeutic strategies related to this significant health priority in Latin America, given the rising incidence and mortality rates at very early stages of treatment.Recent studies illuminate the genetic, environmental, and socioeconomic factors contributing to the high incidence rates of childhood leukemia in Latin America. This Research Topic includes a review of the role of genetic variation and Indigenous American ancestry in the etiology of childhood leukemias. It also discusses future research directions aimed at enhancing our understanding of the disparities in ALL incidence and outcomes among children of Latin American origin, insights that are crucial for informing future precision prevention efforts (de Smith et al).One notable study examined the interaction between specific genetic variants related to glucocorticoid secretion and birth characteristics in relation to ALL risk, building on previous hypotheses that endogenous cortisol may influence the elimination of preleukemic clones formed in utero. This study underscores the potential role of genes regulating the hypothalamic-pituitary-adrenal (HPA) axis in leukemia development, warranting further validation of these findings (de Carvalho et al).Additionally, a population-based study from Puebla, Tlaxcala, and Oaxaca reports incidence rates consistent with trends observed in other Latin American regions, identifying peaks for both lymphoblastic and myeloid leukemias. Variations among subregions may be linked to social and ethnic factors, highlighting the urgent need for targeted research into the socio-environmental determinants of leukemia (Flores-Lujano et al).A spatial analysis in Greater Mexico City further elucidates the potential environmental influences on leukemia incidence. Significant clustering of ALL cases is observed, with a relative risk indicating heightened incidence in identified clusters. Proximity to electrical installations and petrochemical facilities suggests that environmental factors contribute to leukemia risk, emphasizing the necessity for further investigation and preventive measures in high-risk areas (Duarte-Rodriguez et al). Moreover, in another research ALL clusters potentially associated with carcinogenic sources, leading to higher risks of poor outcomes were identified (Calderon-Hernández et al).Finally, two large case-control studies examine the impact of maternal diet during pregnancy on the risk of childhood leukemias in infants (Mérida-Ortega et al; Pérez-Saldívar et al)A study featured in this Research Topic employs comprehensive profiling tools to identify unique biomarkers and microenvironment characteristics, advocating for early and personalized risk stratification. This approach has the potential to significantly enhance treatment strategies and improve patient outcomes. The focus on patient stratification and risk prediction has provided valuable insights, particularly regarding a subtype of ProB-ALL in Mexican children from vulnerable regions, which is linked to a higher risk of measurable residual disease (MRD) (Romo-Rodriguez et al).In another study, the authors characterize the systemic immunological profile of children undergoing treatment for B-ALL, evaluating various cell populations, chemokines, and cytokines as potential biomarkers for clinical follow-up. Given the challenges of monitoring immune cells and molecules, periphe -Abstract Truncated-

Frequency of polymorphisms in the IKZF1 and CDKN2A/2B genes and descriptive analysis in pediatric patients with acute lymphoblastic leukemia: a multicenter hospital-based prevalence study in Rio De Janeiro

Banding cytogenetic analysis in pediatric patients with acute lymphoblastic leukemia (ALL) in a Brazilian population

Spectrum and Clinical Features of Gene Mutations in Chinese Pediatric Acute Lymphoblastic Leukemia

Hematological and Biochemical Characteristics Associated with Cytogenetic Findern Alterations in Adult Patients with Acute Lymphoblastic Leukemia (ALL) from the Northern Region of Brazil

Molecular Characterization of Pediatric Acute Lymphoblastic Leukemia via Integrative Transcriptomics: A Multicenter Study in Argentina

Clinical and Genetic Characteristics of <i>IKZF1</i> Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia

The genomic landscape of pediatric acute lymphoblastic leukemia

Immunophenotypic and Cytogenetic Characteristics of Pediatric Acute Lymphoblastic Leukemia: A Burden Estimation Study from Eastern India

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children

Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.

Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia

Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic Leukemia

Editorial: Childhood leukemias in Latin America: epidemiology, causality, novel predictive profiles and therapeutic strategies

Pediatric Acute Promyelocytic Leukemia in Brazil: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome

Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia

Unraveling Copy Number Alterations in Pediatric B-Cell Acute Lymphoblastic Leukemia: Correlation with Induction Phase Remission Using MLPA

Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients

Abstract 4516: Rare High-Penetrance and Common Low-Penetrance Variants Associated with Risk of Pediatric Acute Lymphoblastic Leukemia

Survival analysis of haematologic neoplasms in children and adolescents: a population-based study in a state of the Brazilian Legal Amazon

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort

Meta-analysis of polymorphic variants conferring acute lymphoblastic leukemia risk in the Indian population